De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Bancorp Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Bancorp heeft totale activa van $8.1B en een totaal eigen vermogen van $777.0M. De totale stortingen zijn $7.2B |number_shorten( $5.6B. Het verdient een netto rentemarge van 5%. Er is voldoende voorziening voor slechte leningen, die momenteel 0.3% van de totale leningen bedragen. Contant geld en kortetermijninvesteringen zijn $5.7M.

Belangrijke informatie

10.5x

Verhouding activa / eigen vermogen

5.0%

Nettorentemarge

Totaal deposito's	US$7.16b
Verhouding leningen/deposito's	Passend
Slechte leningen	0.3%
Voorziening voor dubieuze leningen	Voldoende
Huidige ratio	Laag
Geldmiddelen en kasequivalenten	US$5.74m

Recente financiële gezondheidsupdates

Geen updates

Recent updates

Analysts' Revenue Estimates For The Bancorp, Inc. (NASDAQ:TBBK) Are Surging Higher

Jan 28

Do Bancorp's (NASDAQ:TBBK) Earnings Warrant Your Attention?

Jan 23

If EPS Growth Is Important To You, Bancorp (NASDAQ:TBBK) Presents An Opportunity

Sep 08

Here's Why We Think Bancorp (NASDAQ:TBBK) Might Deserve Your Attention Today

May 24

Need To Know: Analysts Are Much More Bullish On The Bancorp, Inc. (NASDAQ:TBBK) Revenues

Jan 31

Is Now The Time To Put Bancorp (NASDAQ:TBBK) On Your Watchlist?

Dec 09

Rainbows and Unicorns: The Bancorp, Inc. (NASDAQ:TBBK) Analysts Just Became A Lot More Optimistic

Nov 01

Is Now The Time To Put Bancorp (NASDAQ:TBBK) On Your Watchlist?

Aug 23

Is Now The Time To Put Bancorp (NASDAQ:TBBK) On Your Watchlist?

Apr 29

Need To Know: Analysts Are Much More Bullish On The Bancorp, Inc. (NASDAQ:TBBK) Revenues

Feb 07

The Bancorp: A Unique Growth Story

Jan 12

Here's Why We Think Bancorp (NASDAQ:TBBK) Is Well Worth Watching

Dec 16

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Analyse financiële instellingen

Activa niveau: De Vermogen/vermogensverhouding ( 10.5 x) TBBK is gematigd.

Voorziening voor slechte leningen: TBBK heeft een voldoende voorziening voor slechte leningen ( 149 %).

Laag risico verplichtingen: 97% van de verplichtingen van TBBK bestaan voornamelijk uit laag risico financieringsbronnen.

Leenniveau: TBBK heeft een passend niveau van Leningen/activa-ratio ( 68% ).

Laag risico deposito's: De Leningen-depositoverhouding ( 78% ) van TBBK } is passend.

Niveau van slechte leningen: TBBK heeft een passend niveau van slechte leningen ( 0.3 %).

Bancorp Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Recent updates

Should You Be Adding Bancorp (NASDAQ:TBBK) To Your Watchlist Today?

The Bancorp, Inc. Announces Todd Brockman to Join Its Board of Directors, Effective October 1, 2024

New minor risk - Insider selling

Price target increased by 21% to US$56.67

The Bancorp: Fintech Solutions Push The Bank To New All-Time Highs

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Investor sentiment improves as stock rises 16%

The Bancorp, Inc. to Report Q2, 2024 Results on Jul 25, 2024

The Bancorp, Inc. Appoints Mark Tryniski to Its Board of Directors

Insider recently bought US$621k worth of stock

The Bancorp Deserves More Time For The Bullish Thesis To Play Out

Insider notifies of intention to sell stock

First quarter 2024 earnings: Revenues and EPS in line with analyst expectations

Does Bancorp (NASDAQ:TBBK) Deserve A Spot On Your Watchlist?

The Bancorp, Inc. to Report Q1, 2024 Results on Apr 25, 2024

Price target decreased by 7.0% to US$48.67

The Bancorp, Inc., Annual General Meeting, May 29, 2024

Investor sentiment deteriorates as stock falls 17%

Full year 2023 earnings: EPS misses analyst expectations

Insider notifies of intention to sell stock

Insider recently sold US$323k worth of stock

Independent Director recently bought US$421k worth of stock

The Bancorp: An Atypical Bank That Keeps Growing

Price target increased by 13% to US$53.33

Analysts' Revenue Estimates For The Bancorp, Inc. (NASDAQ:TBBK) Are Surging Higher

Full year 2023 earnings: EPS misses analyst expectations

Do Bancorp's (NASDAQ:TBBK) Earnings Warrant Your Attention?

The Bancorp, Inc. to Report Q4, 2023 Results on Jan 25, 2024

New major risk - Shareholder dilution

Investor sentiment improves as stock rises 17%

Consensus revenue estimates decrease by 11%

Third quarter 2023 earnings: EPS in line with expectations, revenues disappoint

The Bancorp, Inc. to Report Q3, 2023 Results on Oct 26, 2023

Insider notifies of intention to sell stock

If EPS Growth Is Important To You, Bancorp (NASDAQ:TBBK) Presents An Opportunity

Independent Director recently bought US$221k worth of stock

Independent Director recently bought US$221k worth of stock

Consensus revenue estimates increase by 11%

Price target increased by 11% to US$45.00

Second quarter 2023 earnings: EPS exceeds analyst expectations

The Bancorp, Inc. Provides Earnings Guidance for the Year 2023 and 2024

Investor sentiment improves as stock rises 15%

The Bancorp, Inc. to Report Q2, 2023 Results on Jul 27, 2023

Investor sentiment improves as stock rises 16%

Executive VP & General Counsel notifies of intention to sell stock

Here's Why We Think Bancorp (NASDAQ:TBBK) Might Deserve Your Attention Today

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

Independent Director recently bought US$73k worth of stock

Investor sentiment deteriorates as stock falls 25%

Insider recently sold US$153k worth of stock

Investor sentiment improves as stock rises 17%

Need To Know: Analysts Are Much More Bullish On The Bancorp, Inc. (NASDAQ:TBBK) Revenues

Full year 2022 earnings: EPS in line with analyst expectations despite revenue beat

The Bancorp, Inc. Updates Earnings Guidance for the Year 2023

The Bancorp, Inc. to Report Q4, 2022 Results on Jan 26, 2023

Is Now The Time To Put Bancorp (NASDAQ:TBBK) On Your Watchlist?

Price target increased to US$35.00

Independent Director recently bought US$585k worth of stock

Rainbows and Unicorns: The Bancorp, Inc. (NASDAQ:TBBK) Analysts Just Became A Lot More Optimistic

Price target increased to US$35.00

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

The Bancorp, Inc. (NasdaqGS:TBBK) announces an Equity Buyback for $100 million worth of its shares.

The Bancorp, Inc. to Report Q3, 2022 Results on Oct 27, 2022

Price target decreased to US$32.00

Independent Chairman of the Board exercised options to buy US$116k worth of stock.

Is Now The Time To Put Bancorp (NASDAQ:TBBK) On Your Watchlist?

Second quarter 2022 earnings: EPS exceeds analyst expectations

Investor sentiment improved over the past week

The Bancorp, Inc. to Report Q2, 2022 Results on Jul 28, 2022

Investor sentiment improved over the past week

Independent Director exercised options to buy US$90k worth of stock.

Investor sentiment deteriorated over the past week

First quarter 2022 earnings: EPS in line with expectations, revenues disappoint

Is Now The Time To Put Bancorp (NASDAQ:TBBK) On Your Watchlist?

The Bancorp, Inc. to Report Q1, 2022 Results on Apr 28, 2022